| Patent | Date |
|---|
Serum Albumin-binding Fibronectin Type Iii Domains
App 20220204589 - MITCHELL; Tracy S. ; et al. | 2022-06-30 |
PET imaging with PD-L1 binding polypeptides
Grant 11,344,639 - Morin , et al. May 31, 2 | 2022-05-31 |
Therapeutic And Diagnostic Methods For Cancer
App 20220153861 - BOURGON; Richard ; et al. | 2022-05-19 |
Therapeutic and diagnostic methods for cancer
Grant 11,300,570 - Fabrizio , et al. April 12, 2 | 2022-04-12 |
Therapeutic and diagnostic methods for cancer
Grant 11,279,767 - Bourgon , et al. March 22, 2 | 2022-03-22 |
Novel Pd-l1 Binding Polypeptides For Imaging
App 20220001040 - MORIN; Paul E. ; et al. | 2022-01-06 |
Serum albumin-binding fibronectin type III domains
Grant 11,203,630 - Mitchell , et al. December 21, 2 | 2021-12-21 |
PD-L1 binding polypeptides for imaging
Grant 11,173,219 - Morin , et al. November 16, 2 | 2021-11-16 |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
Grant 11,149,077 - Camphausen , et al. October 19, 2 | 2021-10-19 |
Serum albumin binding molecules
Grant 10,934,572 - Gosselin , et al. March 2, 2 | 2021-03-02 |
Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
App 20210040181 - CAMPHAUSEN; Ray ; et al. | 2021-02-11 |
Targeted therapeutics based on engineered proteins that bind EGFR
Grant 10,781,247 - Camphausen , et al. Sept | 2020-09-22 |
Compositions And Methods For Evaluating Genomic Alterations
App 20200149097 - Otto; Geoffrey Alan ; et al. | 2020-05-14 |
Serum Albumin-binding Fibronectin Type Iii Domains
App 20200048328 - MITCHELL; Tracy S. ; et al. | 2020-02-13 |
Novel Pd-l1 Binding Polypeptides For Imaging
App 20190343972 - Morin; Paul E. ; et al. | 2019-11-14 |
Serum albumin-binding fibronectin type III domains
Grant 10,442,851 - Mitchell , et al. Oc | 2019-10-15 |
PD-L1 binding polypeptides for imaging
Grant 10,406,251 - Morin , et al. Sept | 2019-09-10 |
Therapeutic And Diagnostic Methods For Cancer
App 20190219586 - Fabrizio; David ; et al. | 2019-07-18 |
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20190202894 - CAMPHAUSEN; Ray ; et al. | 2019-07-04 |
Serum Albumin Binding Molecules
App 20190203248 - GOSSELIN; Michael L. ; et al. | 2019-07-04 |
Pet Imaging With Pd-l1 Binding Polypeptides
App 20190184042 - MORIN; Paul E. ; et al. | 2019-06-20 |
Methods of treating cancer by administering IGF-IR binding molecules
Grant 10,221,232 - Camphausen , et al. | 2019-03-05 |
Serum albumin binding molecules
Grant 10,221,438 - Gosselin , et al. | 2019-03-05 |
Therapeutic And Diagnostic Methods For Cancer
App 20190025308 - CUMMINGS; Craig Anthony ; et al. | 2019-01-24 |
Therapeutic And Diagnostic Methods For Cancer
App 20180371099 - BOURGON; Richard ; et al. | 2018-12-27 |
Methods And Systems For Evaluating Tumor Mutational Burden
App 20180363066 - Chalmers; Zachary R. ; et al. | 2018-12-20 |
Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
App 20180244755 - CAMPHAUSEN; Ray ; et al. | 2018-08-30 |
Targeted therapeutics based on engineered proteins that bind EGFR
Grant 9,920,108 - Camphausen , et al. March 20, 2 | 2018-03-20 |
Novel Pd-l1 Binding Polypeptides For Imaging
App 20170258948 - MORIN; Paul E. ; et al. | 2017-09-14 |
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20170190761 - CAMPHAUSEN; Ray ; et al. | 2017-07-06 |
Serum Albumin-binding Fibronectin Type Iii Domains
App 20170174748 - MITCHELL; Tracy S. ; et al. | 2017-06-22 |
Serum Albumin Binding Molecules
App 20170145464 - GOSSELIN; Michael L. ; et al. | 2017-05-25 |
Serum albumin binding molecules
Grant 9,540,424 - Gosselin , et al. January 10, 2 | 2017-01-10 |
Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
App 20160152688 - CAMPHAUSEN; Ray ; et al. | 2016-06-02 |
Targeted therapeutics based on engineered proteins that bind EGFR
Grant 9,234,028 - Camphausen , et al. January 12, 2 | 2016-01-12 |
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20150252097 - CAMPHAUSEN; Ray ; et al. | 2015-09-10 |
Serum Albumin Binding Molecules
App 20150152147 - GOSSELIN; Michael L. ; et al. | 2015-06-04 |
Serum albumin binding molecules
Grant 8,969,289 - Gosselin , et al. March 3, 2 | 2015-03-03 |
Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
App 20140038893 - CAMPHAUSEN; Ray ; et al. | 2014-02-06 |
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20130310317 - CAMPHAUSEN; Ray ; et al. | 2013-11-21 |
Targeted therapeutics based on engineered proteins that bind EGFR
Grant 8,524,244 - Camphausen , et al. September 3, 2 | 2013-09-03 |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
Grant 8,470,332 - Camphausen , et al. June 25, 2 | 2013-06-25 |
Serum Albumin Binding Molecules
App 20110305663 - Gosselin; Michael L. ; et al. | 2011-12-15 |
Targeted Therapeutics Based On Engineered Proteins That Bind Egfr
App 20110053842 - Camphausen; Ray ; et al. | 2011-03-03 |
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20100121033 - Camphausen; Ray ; et al. | 2010-05-13 |
| 